Compliance: Why Is Lab Work on the OIG Hit List?

Why This Topic Matters

Laboratory services represent a large share of Medicare Part B spending, so payment changes and oversight initiatives can affect reimbursement, compliance exposure, and operational planning for labs and ordering providers.

Article Sections

1. Background

   Introduces the federal oversight context for clinical laboratory services and summarizes recent Medicare improper payment reporting related to lab testing.

2. Consider These Recent Stats

   Reviews payment and utilization statistics for laboratory testing, including references to recent federal reports and fee schedule developments.

3. Result

   Describes the addition of a laboratory payment monitoring topic to the federal work plan and places it in the broader compliance and enforcement environment.

4. Warning

   Highlights the risk of improper financial relationships and enforcement consequences tied to laboratory-related claims and arrangements.